180 Wealth Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

180 Wealth Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-25,000	Closed	-$26K	–	282
2019 Q3	$26K	Hold	25,000	–	–	0.01%	251
2019 Q2	$35K	Hold	25,000	–	–	0.02%	246
2019 Q1	$43K	Sell	25,000 -5,000	-17%	-$7.32K	0.02%	249
2018 Q4	$81K	Hold	30,000	–	–	0.04%	250
2018 Q3	$81K	Hold	30,000	–	–	0.04%	250
2018 Q2	$57K	Buy	30,000 +10,000	+50%	+$20.2K	0.03%	239
2018 Q1	$42K	Buy	+20,000	New	+$42.9K	0.02%	229

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

180 Wealth Advisors's INFI Position: Q4 2019 in Review

180 Wealth Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2019, closing a stake of 25,000 shares — an estimated $26K sold.

180 Wealth Advisors first reported a position in INFI in Q1 2018 and held it in 7 quarters. The position peaked at $81K in Q4 2018. 47 funds tracked by Wall St. Rank hold INFI as of Q4 2019.

180 Wealth Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
180 Wealth Advisors sold 25,000 Infinity Pharmaceuticals, Inc. shares in Q4 2019, an estimated $26K.
180 Wealth Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2018 and held it in 7 quarters.
180 Wealth Advisors's Infinity Pharmaceuticals, Inc. position peaked at $81K in Q4 2018.
47 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2019.

Based on 180 Wealth Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.